PMCB   $1.52  -3.80% Market Closed

PharmaCyte Biotech Inc
Total Cash 32.64M
totalCashPerShare 4.25
EBITDA
Total Debt 0.00
quickRatio 4.367
currentRatio 4.399
Total Revenue
debtToEquity
Revenue/Share
ROA -0.04759
ROE 0.4788
grossProfits
freeCashflow 3.13M
operatingCashflow -2.87M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -13.02M
forwardPE
floatShares 7.29M
sharesOutstanding 7.68M
sharesShort 21.05K
sharesShortPriorMonth 17.22K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.16%
Short Ratio help_outline 0.63%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 6.182
Price To Book help_outline 0.30
earningsQuarterlyGrowth
netIncomeToCommon 4.50M
trailingEps 0.68%
forwardEps -0.38%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 39
lastUpdated Nov. 7, 2024, 5:14 a.m.